Cervical Intraepithelial Neoplasia Grade 2/3 Clinical Trial
Official title:
Validation of Human Papillomavirus Assays and Collection Devices for HPV Testing on Self-samples and First-void Urine Samples (VALHUDES)
The VALHUDES study is a Diagnostic Test Accuracy study that aims to document the clinical accuracy of hrHPV testing on urine samples, collected under standardised and optimised conditions, and on two types of vaginal self-samples and compare results with those from matching samples taken by a clinician.
The samples are collected from patients referred to colposcopy because of prior cervical abnormalities. The patient takes at home two urine samples with the Colli-Pee device (a device that allows to collect first-void urine), the day before the visit to the colposcopy centre. At the colposcopy centre, two vaginal self-samples are taken by the patient herself: one with a cotton swab and a second with a plastic brush. Finally, the gynecologist takes a cervical Pap smear with a Cervex-Brush Combi. A real-time PCR test will be used to detect DNA of high-risk HPV types. It is possible that in the future also other tests will be validated on these samples. The colposcopy and histological findings will be used as the gold standard. The main purpose of the study is to assess the relative diagnostic tests accuracy of hrHPV testing on self- and urine samples compared to hrHPV testing on cervical samples taken by a clinician. Furthermore, the participating women will receive also a questionnaire which can give insights into the attitudes and preferences of the women with regard to the self-sampling devices. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03196180 -
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
|
Early Phase 1 | |
| Active, not recruiting |
NCT04484415 -
Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)
|
Phase 3 | |
| Not yet recruiting |
NCT06258564 -
The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
|
||
| Recruiting |
NCT04788849 -
Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples
|
||
| Not yet recruiting |
NCT06273553 -
A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT02149030 -
Effectiveness of Cervical Screening in HPV Vaccinated Women
|
Phase 4 | |
| Completed |
NCT01550783 -
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
|
N/A | |
| Enrolling by invitation |
NCT04755517 -
Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400)
|
N/A | |
| Completed |
NCT02811367 -
The HPV Self-test as a Test of Cure in Madagascar
|
N/A | |
| Completed |
NCT00081263 -
Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
|
Phase 2 | |
| Recruiting |
NCT05405270 -
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
|
||
| Completed |
NCT04312737 -
Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus
|
||
| Completed |
NCT02067468 -
Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia
|
N/A | |
| Completed |
NCT02354534 -
Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
|
Phase 1 | |
| Recruiting |
NCT03366493 -
The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection
|
Phase 3 | |
| Recruiting |
NCT05851079 -
Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions
|
||
| Recruiting |
NCT03274206 -
A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
|
Phase 2 |